Author results

6G5F
  • Download 6g5f
  • View 6g5f
Molmil generated image of 6g5f
CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1
Descriptor:Botulinum neurotoxin type B, Synaptotagmin-1, GLYCEROL, ...
Authors:Masuyer, G., Elliot, M., Favre-Guilmard, C., Liu, S.M., Maignel, J., Beard, M., Carre, D., Kalinichev, M., Lezmi, S., Mir, I., Nicoleau, C., Palan, S., Perier, C., Raban, E., Dong, M., Krupp, J., Stenmark, P.
Deposit date:2018-03-29
Release date:2019-01-16
Last modified:2019-02-20
Method:X-RAY DIFFRACTION (2.5 Å)
Cite:Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Sci Adv, 5, 2019
6G5G
  • Download 6g5g
  • View 6g5g
Molmil generated image of 6g5g
CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B MUTANT E1191M/S1199Y IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 2
Descriptor:Botulinum neurotoxin type B, Synaptotagmin 2, MAGNESIUM ION, ...
Authors:Masuyer, G., Elliot, M., Favre-Guilmard, C., Liu, S.M., Maignel, J., Beard, M., Carre, D., Kalinichev, M., Lezmi, S., Mir, I., Nicoleau, C., Palan, S., Perier, C., Raban, E., Dong, M., Krupp, J., Stenmark, P.
Deposit date:2018-03-29
Release date:2019-01-16
Last modified:2019-02-20
Method:X-RAY DIFFRACTION (2 Å)
Cite:Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Sci Adv, 5, 2019
6G5K
  • Download 6g5k
  • View 6g5k
Molmil generated image of 6g5k
CRYSTAL STRUCTURE OF THE BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE B IN COMPLEX WITH HUMAN SYNAPTOTAGMIN 1
Descriptor:Botulinum neurotoxin type B, Synaptotagmin-1
Authors:Masuyer, G., Elliot, M., Favre-Guilmard, C., Liu, S.M., Maignel, J., Beard, M., Carre, D., Kalinichev, M., Lezmi, S., Mir, I., Nicoleau, C., Palan, S., Perier, C., Raban, E., Dong, M., Krupp, J., Stenmark, P.
Deposit date:2018-03-29
Release date:2019-01-16
Last modified:2019-02-20
Method:X-RAY DIFFRACTION (2 Å)
Cite:Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Sci Adv, 5, 2019